<ѻýҕl>Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trialsѻýҕl> News, features, and commentary about cancer-related issues Jun 28, 2024
<ѻýҕl>Combo of Approved Agents Active in High-Risk Large B-Cell Lymphomaѻýҕl> Our panel of experts discusses mosunetuzumab/polatuzumab vedotin for relapsed/refractory patients Jun 25, 2024 video
<ѻýҕl>EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancerѻýҕl> News, features, and commentary about cancer-related issues Jun 21, 2024
<ѻýҕl>Glofitamab Regimen Improves Survival in DLBCLѻýҕl> Granted accelerated approval last year, bispecific antibody passes its confirmatory test Jun 20, 2024
<ѻýҕl>Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCLѻýҕl> High-rate of durable responses with ViPOR sparks talk of supplanting CAR-T in second line Jun 19, 2024
<ѻýҕl>Atezolizumab Consolidation Impresses in High-Risk DLBCLѻýҕl> Will 2-year DFS of 88%, OS of 96% renew interest in checkpoint inhibitor consolidation? Jun 14, 2024
<ѻýҕl>Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?ѻýҕl> News, features, and commentary about cancer-related issues Jun 13, 2024
<ѻýҕl>New Clues to Origin of T-Cell Lymphoma After CAR-T Therapyѻýҕl> Co-mutations, viral link, potential common susceptibility emerge from two studies Jun 12, 2024
<ѻýҕl>Brigatinib Makes Its Case for ALK-Positive ALCL in Small Studyѻýҕl> Second-gen ALK inhibitor induces high response rate, associated with impressive survival Jun 12, 2024
<ѻýҕl>Near-Perfect Control of Slow-Growing Lymphoma With Low-Dose Radiotherapyѻýҕl> All but four of 24 patients had complete responses to 4 Gy, local control rate of 96% at 3 years Jun 06, 2024
<ѻýҕl>Star Singer's Illness; AI Imitating the Dead; Internet-Addicted Brainsѻýҕl> Health news and commentary gathered by ѻýҕl staff Jun 05, 2024
<ѻýҕl>Triplet Notches Survival Win in Heavily Pretreated DLBCLѻýҕl> Benefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant Jun 02, 2024
<ѻýҕl>Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trialѻýҕl> Better efficacy with brentuximab vedotin versus standard chemo, substantially less toxicity Jun 01, 2024
<ѻýҕl>Fewer Suicides in Cancer Patients; Circadian Rhythm Boost; HIV Vaccine for Cancer?ѻýҕl> News, features, and commentary about cancer-related issues May 31, 2024
<ѻýҕl>Tattoos May Be a Risk Factor for Lymphomaѻýҕl> Swedish study suggests a 21% higher risk for lymphoma in those with tattoos May 28, 2024
<ѻýҕl>Cancer and Intimate-Care Products; Boost for CRC Stool Tests; Biopsy by Ultrasound?ѻýҕl> News, features, and commentary about cancer-related issues May 17, 2024
<ѻýҕl>CAR-T Plus Stem-Cell Transplant Promising for CD7+ Blood Cancersѻýҕl> "All-in-one" approach appears safe, effective, in patients with relapsed/refractory disease Apr 24, 2024
<ѻýҕl>Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Testsѻýҕl> News, features, and commentary about cancer-related issues Apr 19, 2024
<ѻýҕl>Immunotherapy During Pregnancy Just as Safe as Other Cancer Drugsѻýҕl> However, use should be avoided "if possible" due to risk of rare immune-related adverse events Apr 17, 2024
<ѻýҕl>Chemo and Heart Disease; Flawed Lung Cancer Screening; New Vax Recommendationsѻýҕl> News, features, and commentary about cancer-related issues Mar 29, 2024
<ѻýҕl>PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphomaѻýҕl> The combination induced responses in all 34 patients with advanced extranodal NK/T-cell lymphoma Mar 28, 2024
<ѻýҕl>Broader Cancer Risk With CAR-T? AI for Physician Burnout; 'Lollipops' ID Oral Cancerѻýҕl> News, features, and commentary about cancer-related issues Mar 22, 2024
<ѻýҕl>Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors Treated With Doxorubicinѻýҕl> Dose-dependent increase regardless of age at treatment or chest radiotherapy Mar 19, 2024
<ѻýҕl>EPA Imposes New Limit on Medical Sterilization Chemical, Citing Cancer Riskѻýҕl> Rule would lower emission standards for ethylene oxide by 90%, agency says Mar 15, 2024
<ѻýҕl>FDA Approves First CAR-T for Chronic Lymphocytic Leukemiaѻýҕl> Lisocabtagene maraleucel (Breyanzi) nabs new indication for relapsed or refractory CLL/SLL Mar 15, 2024
<ѻýҕl>Getting Prostate Cancer Drugs Sooner; Limiting Toxic Emissions; FTC Sues 'Charity'ѻýҕl> News, features, and commentary about cancer-related issues Mar 14, 2024
<ѻýҕl>A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertuѻýҕl> News, features, and commentary about cancer-related issues Mar 07, 2024
<ѻýҕl>Novel Regimens Yield High Response Rates for Older, Hodgkin Lymphoma Patientsѻýҕl> Talk of potential cure for some patients with brentuximab plus dacarbazine or nivolumab Mar 06, 2024
<ѻýҕl>IVF Helps Patients Trying to Build Families. An Alabama Court Put That in Doubtѻýҕl> "Every month that you're not pregnant feels like grief" Mar 05, 2024
<ѻýҕl>Toxic Gas That Sterilizes Medical Devices Prompts Safety Rule Updateѻýҕl> The EPA is set to take action after public outcry Mar 03, 2024
<ѻýҕl>Male Fertility Problems in the Family Linked to Cancer Riskѻýҕl> Low sperm levels were tied to specific cancers in family members Feb 22, 2024
<ѻýҕl>Most Immunocompromised Patients Clear Omicron Infectionsѻýҕl> B-cell malignancies, B-cell treatments associated with longer duration of infection Jan 30, 2024
<ѻýҕl>How Can Cancer Risk Be Cut in Communities Exposed to Toxins?ѻýҕl> Group outlines plan to bring the latest testing and treatment to medically underserved minorities Jan 25, 2024
<ѻýҕl>CAR-T Investigation: FDA Leaders Detail Decision on Cancer Risk Warningѻýҕl> Post-treatment cases grow to 22 since products' initial approvals Jan 24, 2024
<ѻýҕl>FDA Calls for New Boxed Warning on All CAR-T Productsѻýҕl> Most serious warning would alert patients, providers on potential risk for secondary malignancies Jan 23, 2024
<ѻýҕl>Two Million Cancers; Casgevy OK'd for Thalassemia; Rectal Exams and Prostate Cancerѻýҕl> News, features, and commentary about cancer-related issues Jan 19, 2024
<ѻýҕl>Pirtobrutinib Shows Potential in Heavily Pretreated Follicular Lymphomaѻýҕl> "Safety profile is one of the real advantages" of non-covalent BTK inhibitor, says panelist Jan 11, 2024 video
<ѻýҕl>Novel Combination Active in Large B-Cell Lymphoma, Even After CAR-Tѻýҕl> But where mosunetuzumab/polatuzumab vedotin would fit among available options remains a question Jan 11, 2024 video
<ѻýҕl>Carvedilol No Help in Preventing Heart Failure in Childhood Cancer Survivorsѻýҕl> While safe, the results do not support use of the drug in anthracycline-exposed survivors Jan 10, 2024
<ѻýҕl>Axi-Cel Shows Durable Responses, Prolongs Overall Survival in Older LBCL Patientsѻýҕl> Our panel discusses findings from the ZUMA-12 study and the ZUMA-7 study Jan 04, 2024 video